Transgenic Overexpression of Interleukin (IL)-10 in the Lung Causes Mucus Metaplasia, Tissue Inflammation, and Airway Remodeling via IL-13-dependent and -independent Pathways
Open Access
- 1 September 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (38) , 35466-35474
- https://doi.org/10.1074/jbc.m206395200
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Interleukin-13 AntagonismPublished by S. Karger AG ,2001
- Kinetics of IL-10 production after segmental antigen challenge of atopic asthmatic subjectsJournal of Allergy and Clinical Immunology, 2000
- The Bronchoalveolar Lavage Fluid of Cystic Fibrosis Lung Transplant Recipients Demonstrates Increased Interleukin-8 and Elastase and Decreased IL-10Journal of Interferon & Cytokine Research, 1998
- Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes.Journal of Clinical Investigation, 1997
- SYSTEMIC ADMINISTRATION OF CELLULAR INTERLEUKIN-10 CAN EXACERBATE CARDIAC ALLOGRAFT REJECTION IN MICE1,2Transplantation, 1996
- Regulatory effects of interleukin-10 on lung ischemia-reperfusion injuryThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Interleukin-10 regulation in normal subjects and patients with asthmaJournal of Allergy and Clinical Immunology, 1996
- Interleukin-10Annual Review of Immunology, 1993
- Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.The Journal of Experimental Medicine, 1993
- Macrophage deactivation by interleukin 10.The Journal of Experimental Medicine, 1991